Literature DB >> 8781415

Expression and function of receptors for stem cell factor and erythropoietin during lineage commitment of human hematopoietic progenitor cells.

J Olweus1, L W Terstappen, P A Thompson, F Lund-Johansen.   

Abstract

The aim of the present study was to determine whether stem cell factor (SCF) and erythropoietin (EPO) act differently on defined subsets of progenitor cells, and if potential differences correlate with the receptor density on each subset. To investigate this possibility directly, we optimized conditions for the identification and purification of homogeneous progenitor cell subpopulations from human bone marrow. Populations containing 40% and 44% colony forming cells (CFCs) with 99% and 95% purity for the granulomonocytic and erythroid lineage, respectively, were sorted on the basis of differential expression of CD34, CD64, and CD71. In addition, a population containing 67% CFCs, of which 29-43% were CFU-MIX, was sorted from CD34hi CD38loCD50+ cells. Purified progenitor cell subsets were compared directly for responsiveness to SCF and EPO using a short-term proliferation assay. Expression of the receptors for SCF and EPO were then examined on each subset using a flow cytometer modified for high-sensitivity fluorescence measurements. The results show that EPO induces extensive proliferation of erythroid progenitor cells, but has no effect on the proliferation or survival of primitive or granulomonocytic progenitors, even when used in combination with other cytokines. The majority of erythroid progenitor cells furthermore stained positively with anti-EPO receptor (EPO-R) monoclonal antibodies, whereas other progenitor cells were negative. SCF alone induced extensive proliferation of erythroid progenitor cells, and had a stronger synergistic effect on primitive than on granulo-monocytic progenitors. In spite of these differences in SCF activity, there were no significant differences in SCF-R expression between the progenitor subsets. These results suggest that the selective action of EPO on erythropoiesis is determined by lineage-restricted receptor expression, whereas there are additional cell-type specific factors that influence progenitor cell responses to SCF.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8781415

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin.

Authors:  J Olweus; A BitMansour; R Warnke; P A Thompson; J Carballido; L J Picker; F Lund-Johansen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

2.  Impaired growth and elevated fas receptor expression in PIGA(+) stem cells in primary paroxysmal nocturnal hemoglobinuria.

Authors:  R Chen; S Nagarajan; G M Prince; U Maheshwari; L W Terstappen; D R Kaplan; S L Gerson; J M Albert; D E Dunn; H M Lazarus; M E Medof
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

3.  The human placenta is a hematopoietic organ during the embryonic and fetal periods of development.

Authors:  Alicia Bárcena; Mirhan Kapidzic; Marcus O Muench; Matthew Gormley; Marvin A Scott; Jingly F Weier; Christy Ferlatte; Susan J Fisher
Journal:  Dev Biol       Date:  2008-12-03       Impact factor: 3.582

4.  A new role for the human placenta as a hematopoietic site throughout gestation.

Authors:  Alicia Bárcena; Marcus O Muench; Mirhan Kapidzic; Susan J Fisher
Journal:  Reprod Sci       Date:  2009-02       Impact factor: 3.060

5.  Thrombomucin, a novel cell surface protein that defines thrombocytes and multipotent hematopoietic progenitors.

Authors:  K M McNagny; I Pettersson; F Rossi; I Flamme; A Shevchenko; M Mann; T Graf
Journal:  J Cell Biol       Date:  1997-09-22       Impact factor: 10.539

6.  Proteomic Comparison of Bone Marrow Derived Osteoblasts and Mesenchymal Stem Cells.

Authors:  Elise Aasebø; Annette K Brenner; Maria Hernandez-Valladares; Even Birkeland; Frode S Berven; Frode Selheim; Øystein Bruserud
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

7.  Gata2-L359V impairs primitive and definitive hematopoiesis and blocks cell differentiation in murine chronic myelogenous leukemia model.

Authors:  Ya-Kai Fu; Yun Tan; Bo Wu; Yu-Ting Dai; Xiao-Guang Xu; Meng-Meng Pan; Zhi-Wei Chen; Niu Qiao; Jing Wu; Lu Jiang; Jing Lu; Bing Chen; Avigail Rein; Shai Izraeli; Xiao-Jian Sun; Jin-Yan Huang; Qiu-Hua Huang; Zhu Chen; Sai-Juan Chen
Journal:  Cell Death Dis       Date:  2021-06-02       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.